News Headlines
-
Galapagos And Blood Centers Of America Announce Strategic Collaboration To Accelerate Galapagos’ Decentralized CAR-T Manufacturing Network In The U.S.
5/15/2024
Galapagos NV and Blood Centers of America (BCA) today announced that they have entered into a strategic collaboration for the decentralized manufacturing of Galapagos’ CAR-T cell therapies through BCA’s network in the U.S.
-
Renaissance Lakewood, LLC Opens New Headquarters Global CDMO Makes Additional Investment In Ocean County, NJ Campus
5/14/2024
Renaissance Lakewood, LLC, a leading pharmaceutical contract development and manufacturing organization (CDMO), today announced the official opening of their new headquarters at 1215 Paco Way in Lakewood, NJ.
-
Efficient Processes In The Pharmaceutical Industry: Körber Simplifies The Integration Of PAS-X MES With Syntegon Packaging Systems
5/14/2024
The international technology group Körber has certified Syntegon, a global manufacturer of pharmaceutical process and packaging technology, as “PAS-X MSI Plug & Produce Ready”.
-
Fulcrum Therapeutics Enters Into A Collaboration And License Agreement With Sanofi For The Development And Commercialization Of Losmapimod In Facioscapulohumeral Muscular Dystrophy
5/13/2024
Fulcrum Therapeutics, Inc.® (Fulcrum) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that it has entered into a collaboration and license agreement with Sanofi (Nasdaq: SNY) for the development and commercialization of losmapimod, an oral small molecule being investigated for the treatment of facioscapulohumeral muscular dystrophy (FSHD).
-
TriLink BioTechnologies Collaborates With Johns Hopkins University To Establish A New RNA Innovation Center
5/13/2024
TriLink BioTechnologies (TriLink), a Maravai LifeSciences company and global provider of life science reagents and services, is collaborating with the Johns Hopkins University to accelerate transformational research in RNA therapeutics and discovery.
-
Aldevron Announces Strategic Partnership With Acuitas Therapeutics
5/13/2024
Aldevron, a leading global manufacturer of DNA, RNA, and proteins used in cell and gene therapies and vaccine development, today announced it has entered a strategic partnership with Acuitas Therapeutics, Inc., a private biotechnology company specializing in the development of delivery systems for nucleic acid therapeutics based on lipid nanoparticles (LNPs).
-
PharmaLogic Announces Opening Of Radiopharmaceutical Production Facility In New York City
5/13/2024
PharmaLogic Holdings Corp., ("PharmaLogic" or "the company"), a world-class contract development and manufacturing organization (CDMO) and radiopharmacy solutions provider, celebrates the opening of its radiopharmaceutical production and research facility in the Bronx, New York.
-
PHARMAP 2024 Highlights: From Cryogenic Storage To Patient-Centric Design
5/13/2024
PHARMAP 2024 brought together over 330 professionals from across the industry's value chain. Among attendees were contract manufacturing organisations, service providers and experts.
-
Ribobay Pharma Boosts CRDMO Offerings With Cytiva's First FlexFactory Platform For Oligonucleotides
5/10/2024
Ribobay Pharma, a leading Chinese biopharmaceutical contract research, development, and manufacturing organization (CRDMO) and a spin-off company of General Biol (Anhui) Co., Ltd, will provide cGMP-level oligonucleotide (oligo) CRDMO services to the world using Cytiva's first FlexFactory platform for oligo manufacturing.
-
ExcellGene SA And Cytovance Biologics Join Forces To Transform Large Molecule Biologics Development And Manufacture
5/8/2024
ExcellGene SA, a leading Swiss biotech service provider specializing in mammalian cell line development for more than two decades, proudly announces its strategic collaboration with Cytovance Biologics, a renowned Contract Development and Manufacturing Organization (CDMO) based in the USA.